179 related articles for article (PubMed ID: 25678754)
1. Growth failure starts from early infancy in children with short stature at age 6.
Noda M; Sato N; Tanaka T
Clin Pediatr Endocrinol; 2015 Jan; 24(1):1-10. PubMed ID: 25678754
[TBL] [Abstract][Full Text] [Related]
2. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency.
Sas T; Mulder P; Hokken-Koelega A
J Clin Endocrinol Metab; 2000 Oct; 85(10):3786-92. PubMed ID: 11061539
[TBL] [Abstract][Full Text] [Related]
3. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.
de Zegher F; Du Caju MV; Heinrichs C; Maes M; De Schepper J; Craen M; Vanweser K; Malvaux P; Rosenfeld RG
J Clin Endocrinol Metab; 1999 May; 84(5):1558-61. PubMed ID: 10323379
[TBL] [Abstract][Full Text] [Related]
4. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
Cohen P; Germak J; Rogol AD; Weng W; Kappelgaard AM; Rosenfeld RG;
J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.
Wit JM; Boersma B; de Muinck Keizer-Schrama SM; Nienhuis HE; Oostdijk W; Otten BJ; Delemarre-Van de Waal HA; Reeser M; Waelkens JJ; Rikken B
Clin Endocrinol (Oxf); 1995 Apr; 42(4):365-72. PubMed ID: 7750190
[TBL] [Abstract][Full Text] [Related]
6. Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis.
Wassenaar MJ; Dekkers OM; Pereira AM; Wit JM; Smit JW; Biermasz NR; Romijn JA
J Clin Endocrinol Metab; 2009 Oct; 94(10):3721-30. PubMed ID: 19584188
[TBL] [Abstract][Full Text] [Related]
7. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
Colmenares A; González L; Gunczler P; Lanes R
J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
[TBL] [Abstract][Full Text] [Related]
8. Intelligence and psychosocial functioning during long-term growth hormone therapy in children born small for gestational age.
van Pareren YK; Duivenvoorden HJ; Slijper FS; Koot HM; Hokken-Koelega AC
J Clin Endocrinol Metab; 2004 Nov; 89(11):5295-302. PubMed ID: 15531473
[TBL] [Abstract][Full Text] [Related]
9. Effect of Growth Hormone on Final Height in Children with Idiopathic Short Stature: A UAE, Eastern Region Experience.
Mreish S; Kaplan W; Chedid F
Oman Med J; 2017 Nov; 32(6):467-470. PubMed ID: 29218122
[TBL] [Abstract][Full Text] [Related]
10. Reduced concentration of serum growth hormone-binding protein in children with idiopathic short stature. National Cooperative Growth Study.
Carlsson LM; Attie KM; Compton PG; Vitangcol RV; Merimee TJ
J Clin Endocrinol Metab; 1994 Jun; 78(6):1325-30. PubMed ID: 8200933
[TBL] [Abstract][Full Text] [Related]
11. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment.
Spagnoli A; Branca F; Spadoni GL; Cianfarani S; Pasquino AM; Argirò G; Vitale S; Robins SP; Boscherini B
J Clin Endocrinol Metab; 1996 Oct; 81(10):3589-93. PubMed ID: 8855806
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Quality of Life in Children with GH Deficiency and Idiopathic Short Stature Using the Child Behavior Checklist.
Tanaka T; Tai S; Morisaki Y; Tachibana K; Kambayashi Y; Chihara K; Seino Y; Fujieda K
Clin Pediatr Endocrinol; 2009; 18(1):15-22. PubMed ID: 24790375
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of Clinical Features and Growth Hormone Deficiency in Short Children Born Small For Gestational Age].
Ikegami T; Araki S; Kuwamura M; Taku A; Saito R; Goto M; Kubo K; Kawagoe R; Yamamoto Y; Kawada Y; Kusuhara K
J UOEH; 2018; 40(3):253-257. PubMed ID: 30224622
[TBL] [Abstract][Full Text] [Related]
14. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA
Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
[TBL] [Abstract][Full Text] [Related]
15. Effect of growth hormone treatment on quality of life in Japanese children with growth hormone deficiency: an analysis from a prospective observational study.
Tanaka T; Hasegawa T; Ozono K; Tanaka H; Kanzaki S; Yokoya S; Chihara K; Iwamoto N; Seino Y
Clin Pediatr Endocrinol; 2014 Jul; 23(3):83-92. PubMed ID: 25110392
[TBL] [Abstract][Full Text] [Related]
16. Response to growth hormone according to provocation test results in idiopathic short stature and idiopathic growth hormone deficiency.
Yoon JY; Cheon CK; Lee JH; Kwak MJ; Kim HJ; Kim YJ; Lee JE; Chung WY; Kim J; Yoo JH
Ann Pediatr Endocrinol Metab; 2022 Mar; 27(1):37-43. PubMed ID: 35038835
[TBL] [Abstract][Full Text] [Related]
17. Differences in Response to Recombinant Growth Hormone Therapy on Height Gain in Patients with Idiopathic Short Stature Vs. Patients with Growth Hormone Deficiency.
Alzahrani AK; Algethami AK; Barnawi G; Meftah IA; Alshanqiti A; Al-Hashmi H; Khan MA; Felimban N
Cureus; 2020 Mar; 12(3):e7319. PubMed ID: 32313760
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature.
Kriström B; Aronson AS; Dahlgren J; Gustafsson J; Halldin M; Ivarsson SA; Nilsson NO; Svensson J; Tuvemo T; Albertsson-Wikland K
J Clin Endocrinol Metab; 2009 Feb; 94(2):483-90. PubMed ID: 19001519
[TBL] [Abstract][Full Text] [Related]
20. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
Högler W; Briody J; Moore B; Lu PW; Cowell CT
Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
